Refine by
Infection Risks To Protect Articles & Analysis
18 news found
Almost anyone with a weakened or suppressed immune system could be at a heightened risk of developing an invasive mold infection (IMI). Two of the most common IMIs include invasive aspergillosis and invasive mucormycosis. ...
Mucormycosis is a rare but serious type of fungal infection caused by a group of fungi known as mucormycetes. Mucor species and Rhizopus species are some of the most common causes of mucormycosis, however there are also other species. The fungi typically live in soil and decaying organic matter. It is frequently a life-threatening infection warns the Centers for Disease Control and Prevention ...
People of all ages are susceptible to getting infected and sick with norovirus. According to the Centers for Disease Control and Prevention (CDC), it is the leading cause of vomiting and diarrhea, and foodborne illness in the United States. The agency also warns that infection with one type of norovirus may not protect an individual against other ...
Proper treatment is essential to prevent the spread of infections and protect both public health and the environment. Refractory materials and silica refractory brick properties step in as critical components in the incineration process, providing the necessary linings for high-temperature furnaces.Heat-Resistant Furnace LiningsIncineration is a widely adopted ...
Airfinity’s risk analysis uses cumulative peak cases and deaths from Hong Kong's BA.1 wave as a proxy for mainland China. ...
In addition to SER-109, SER-155 represents Seres’ second active development program in its Infection Protection franchise. Another poster presentation on June 4 at 1:15-4:15 PM CDT will reprise Phase III trial results of SER-109, an investigational microbiome therapeutic for recurrentC.difficileinfection (rCDI). ...
The SER-109 manufacturing purification process is designed to remove unwanted microbes, thereby reducing the risk of pathogen transmission beyond donor screening alone. The FDA has granted SER-109 Breakthrough Therapy designation and Orphan Drug designation for the treatment of rCDI. ...
“Microbiome-based therapeutics have the potential to protect medically compromised transplant patients from life-threatening infections and GvHD as they start on their road to recovery,” said Matthew Henn, PhD, Chief Scientific Officer at Seres and co-author. ...
The SER-109 manufacturing purification process is designed to remove unwanted microbes, thereby reducing the risk of pathogen transmission beyond donor screening alone. The U.S. ...
Preclinical activities are also underway for additional Infection Protection development candidates, leveraging our prior compelling clinical data in this therapeutic category, for indications such as cancer neutropenia, solid organ transplant, and antimicrobial resistant infections more broadly,” continued Mr. ...
(NASDAQ:CYTO), a company dedicated to addressing unmet medical needs through RNA therapeutics, allergy and viral infection protection, and inner ear therapeutics announced today that Bentrio™ has been approved by the Medical Device Authority of Malaysia and is, therefore, cleared for commercialization in that country. ...
(NASDAQ:CYTO), a company dedicated to addressing unmet medical needs through RNA therapeutics, allergy and viral infection protection, and inner ear therapeutics, today provided a business update on its development activities in RNA therapeutics. ...
BlueWillow Biologics, Inc. today announced that the company will present positive interim data from its phase 1 clinical trial of a novel intranasal anthrax vaccine at a Lightning Talks Session of BARDA’s Industry Day, November 3 and 4, 2021. BlueWillow’s rPA/NE01 anthrax vaccine, BW-1010, developed in collaboration with Porton Biopharma Limited (UK) and funded by the National ...
? Meissa’s intranasal recombinant live attenuated COVID-19 vaccine, MV-014-212, induced mucosal as well as systemic antibodies against SARS-CoV-2 and two variants of concern ? MV-014-212 was built on the company’s AttenuBlock platform and is designed to be appropriately attenuated, genetically stable, and optimized to drive robust, broad, and durable immunity ? Data will be ...
The guidance, in the form of Frequently Asked Questions, aimed at a non-specialist audience is available on the Society’s COVID-19 hub, alongside guidance on managing COVID risk in different sectors and guidance on managing other health risks, such as legionella, as the economy opens up. Speaking on behalf of the Society, BOHS President, Alison Margary ...
Mucus and other airway secretions surrounding influenza viruses when coughed or exhaled from infected individuals may protect the virus in the aerosol phase, even in high humidity environments. Laboratory tests using H1N1 flu viruses aerosolised alongside secretions from a human lung cell culture at a range of humidities showed that both the airborne viruses and settled droplets remained ...
Genome analysis of 234 bulls has put researchers, including several from Wageningen Livestock Research, on the trail of DNA variants which influence particular characteristics in breeding bulls. For example, two variants have proven responsible for disruptions to the development of embryos and for curly hair, which is disadvantageous because more ticks and parasites occur in curly hair than in ...
Today, the IAQ Video Network and Cochrane & Associates announced the release of another online video to help educate people about issues that may impact their health. Their latest educational video discusses bacterial meningitis and the bacteria responsible for the infections. Meningitis is an infection of the protective membranes covering the brain and spinal cord. The condition can be ...